Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperlipoproteinemia Type II | 5 | 2024 | 395 | 0.730 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2024 | 3244 | 0.590 |
Why?
|
Anticholesteremic Agents | 3 | 2024 | 967 | 0.580 |
Why?
|
Glucosides | 1 | 2021 | 512 | 0.540 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 916 | 0.470 |
Why?
|
Thrombomodulin | 1 | 2012 | 105 | 0.380 |
Why?
|
Thrombosis | 2 | 2014 | 2942 | 0.320 |
Why?
|
Gene Frequency | 2 | 2014 | 3647 | 0.300 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4287 | 0.270 |
Why?
|
Hypercholesterolemia | 2 | 2024 | 1141 | 0.240 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2821 | 0.240 |
Why?
|
Arcus Senilis | 1 | 2024 | 4 | 0.240 |
Why?
|
Xanthomatosis | 1 | 2024 | 32 | 0.230 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15498 | 0.230 |
Why?
|
Antigens, CD | 1 | 2014 | 4001 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12143 | 0.220 |
Why?
|
Alleles | 1 | 2014 | 6922 | 0.210 |
Why?
|
Heterozygote | 2 | 2024 | 2803 | 0.170 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2020 | 175 | 0.160 |
Why?
|
Women | 1 | 2020 | 223 | 0.160 |
Why?
|
Atherosclerosis | 2 | 2024 | 3407 | 0.150 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 857 | 0.140 |
Why?
|
Cholesterol, LDL | 3 | 2020 | 2382 | 0.140 |
Why?
|
Triglycerides | 1 | 2024 | 2460 | 0.140 |
Why?
|
Diet, Mediterranean | 1 | 2023 | 740 | 0.140 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 480 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10203 | 0.130 |
Why?
|
Brain Diseases | 1 | 2023 | 1545 | 0.110 |
Why?
|
Registries | 3 | 2024 | 8223 | 0.110 |
Why?
|
Lipids | 2 | 2024 | 3340 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 868 | 0.100 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2013 | 704 | 0.080 |
Why?
|
Risk Factors | 7 | 2024 | 74167 | 0.080 |
Why?
|
Comorbidity | 1 | 2021 | 10498 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4420 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6395 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2012 | 1154 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13502 | 0.060 |
Why?
|
Obesity | 2 | 2024 | 12938 | 0.060 |
Why?
|
Humans | 16 | 2024 | 761423 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 220826 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5840 | 0.050 |
Why?
|
Stereotyping | 1 | 2023 | 239 | 0.050 |
Why?
|
Age Factors | 2 | 2014 | 18400 | 0.040 |
Why?
|
Social Perception | 1 | 2023 | 433 | 0.040 |
Why?
|
Greece | 1 | 2020 | 340 | 0.040 |
Why?
|
Female | 8 | 2024 | 392581 | 0.040 |
Why?
|
Diabetic Angiopathies | 1 | 2024 | 803 | 0.040 |
Why?
|
Male | 7 | 2024 | 360736 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 21341 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2024 | 64651 | 0.040 |
Why?
|
Fatty Liver | 1 | 2024 | 789 | 0.040 |
Why?
|
Aged | 5 | 2024 | 169235 | 0.030 |
Why?
|
Social Stigma | 1 | 2023 | 769 | 0.030 |
Why?
|
Adult | 6 | 2024 | 221148 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1150 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 80582 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6309 | 0.030 |
Why?
|
Thromboembolism | 1 | 2020 | 996 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15941 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18247 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11458 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3081 | 0.020 |
Why?
|
Postmenopause | 1 | 2020 | 2513 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2065 | 0.020 |
Why?
|
Blood Glucose | 1 | 2024 | 6391 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17912 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2413 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58956 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4430 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3061 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3057 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1796 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15717 | 0.020 |
Why?
|
Sepsis | 1 | 2020 | 2585 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12951 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2571 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2734 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3202 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41446 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8641 | 0.010 |
Why?
|
Animals | 1 | 2012 | 168441 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54415 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22168 | 0.010 |
Why?
|
Concepts
(85)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_